💥 Sonavex’s EchoMap™ is FDA Cleared 💥
We are thrilled to share that the newest Sonavex device, EchoMap, received FDA 510(k) clearance.
Read more about it here: https://t.co/dpzvqe8B5y
We are pleased to announce that the @NIH@NIDDKgov has awarded @Sonavex a $2M grant to conduct a clinical trial and seek regulatory clearance of our pipeline product EchoGuide. Read more about it here: https://t.co/akbEBT3cb5
#NIH#NIDDK#EchoGuide#EmpoweredPatientCare
Incredibly proud of each and every @Sonavex team member who worked tirelessly to achieve this exciting pair of milestones and grateful for the physicians and research teams who made this possible. Fired up for an exciting 2024!
We are pleased to announce the successful completion of our prospective multicenter U.S. clinical study of #EchoMark & #EchoSure for AV fistula patients and IDE approval of our randomized controlled trial MAFASA https://t.co/JPrBRZ37kQ
Proud of the @Sonavex team for achieving this major milestone in our reimbursement journey and incredibly grateful for the support from the Renal Physicians Association (RPA) along the way.
Major milestone for @Sonavex this week. I want to reiterate my deep gratitude to the patients, our dedicated collaborators, and our team for making this happen.
@Sonavex has completed enrollment in our prospective multi-center U.S. IDE feasibility study for AV fistula patients. We are beyond grateful to the patients, investigators, research coordinators, and our internal team for everyone’s support and hard work. #EmpoweredPatientCare
Today is #WorldKidneyDay. Kidney disease impacts 850 million people and involves complex, ongoing treatment. At @Sonavex, we are working to improve outcomes for hemodialysis patients with our novel ultrasound technology. For more #WorldKidneyDay info visit https://t.co/EHPqCj7yU9
NEW ISSUED PATENT ALERT! Sonavex was recently issued a broad U.S. patent protecting its EchoMark technology and methods associated with using EchoMark to facilitate vascular ultrasound exams
We are pleased to announce that we have been awarded a $1.7 million grant from the @NIH. This grant will fund the further development of our pipeline product, EchoGuide. Thank you to the @NIH for the ongoing support to help us improve clinical care.
https://t.co/gPwA5ltegj
Latest validation study results published in the Journal of Vascular Access demonstrate that EchoSure, when used by dialysis techs and nurses, is both accurate and precise. Follow the link here to learn more:
https://t.co/9dbfrYQZIS
#EchoMark#EchoSure#avf#dialysisaccess
Proud of my friends Joe/Doug/QX and all at @Canopy. Launched exciting new reusable respirator solution and $1M financing round. More comfortable, more breathable, and costs less per day than a disposable N95. Share, consider purchasing, or investing at https://t.co/5QaG1T42pU
Honored to announce the launch of Canopy and our $1M equity crowd-investing campaign at https://t.co/MMzpd6l3JX. Canopy is a next-gen, reusable respirator that is more comfortable, breathable, and costs less per day than a disposable N95. And it's transparent. Shipping early '21.
Really important opportunity to expand access to breakthrough medical technologies for Medicare beneficiaries — Medicare Proposal Could Spur Medical-Device Investment, via @WSJVC #medtech https://t.co/qfGv6q6dJO
Honored to be chosen from a pool of 1,000+ applicants by @MedTechAwards as one of 50 leading medtech startups transforming the healthcare industry. We're excited to be a 2020 Showcase Company among other impressive companies. https://t.co/YOapNGVrRL
We are pleased to announce that we have raised an additional $3M. This first tranche of our newest financing will support the limited release of #EchoMark and #EchoSure.
The full press release can be found at: https://t.co/oV7w4Y7CZh
Excited to announce that we have received a $3 million Phase IIB Small Business Innovation Research (SBIR) grant from the @NIHsbir . Incredibly grateful to the @NIH for their continued support in helping us pursue #EmpoweredPatientCare#EchoMark#EchoSure
https://t.co/198ppi0C7m